Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective.

"Declarations Competing interestsThe authors declare no competing interests. Ethics statementAll procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study. Conflict of interestThe authors declare that they do not have any commercial interest in the subject of study.The authors did not receive financial support or funding for conduction of this study.GM Haag reports fees for advisory role from Sanofi, Roche, Taiho, Nordic, Lilly, Pfizer, honoraria from Roche, travel grants from Amgen, Ipsen and Celgene; research funding is provided by Nordic and Taiho Pharmaceuticals. There is no relationship to the submitted work. Competing interests The authors declare no competing interests. Conflict of interest The authors declare that they do not have any commercial interest in the subject of study. The authors did not receive financial support or funding for conduction of this study. GM Haag reports fees for advisory role from Sanofi, Roche, Taiho, Nordic, Lilly, Pfizer, honoraria from Roche, travel grants from Amgen, Ipsen and Celgene; research funding is provided by Nordic and Taiho Pharmaceuticals. There is no relationship to the submitted work."

"Funding Open Access funding enabled and organized by Projekt DEAL."